Globus Medical (GMED) PT Raised to $117 at Needham
Needham analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $117.00 (from $114.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
